Sudeepta Dandapat1,2, Edgar A Samaniego1,2,3, Viktor Szeder4, Fazeel M Siddiqui5, Gary R Duckwiler4, Ume Kiddy5, Waldo R Guerrero1,2, Binbin Zheng1, David Hasan3, Colin Derdeyn2, Santiago Ortega-Gutierrez1,2,3. 1. Department of Neurology, University of Iowa Carver College of Medicine, Comprehensive Stroke Center, Iowa City, IA, USA. 2. Department of Radiology, University of Iowa Carver College of Medicine, Comprehensive Stroke Center, Iowa City, IA, USA. 3. Department of Neurosurgery, University of Iowa Carver College of Medicine, Comprehensive Stroke Center, Iowa City, IA, USA. 4. Division of Interventional Neuroradiology, Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. 5. Department of Neurology, Southern Illinois University School of Medicine, Comprehensive Stroke Center, Springfield, IL, USA.
Abstract
BACKGROUND AND PURPOSE: Systemic anticoagulation is the standard treatment for cerebral venous sinus thrombosis (CVST). Several endovascular techniques have been described as salvage therapy for anticoagulation refractory CVST cases. We aim to evaluate the safety and feasibility of endovascular aspiration thrombectomy using the new generation, large bore suction catheters alone or in combination with stentriever devices for the treatment of CVST. METHODS: We collected data on 16 consecutive patients with CVST who received endovascular aspiration thrombectomy at three large academic centers. Second generation reperfusion catheters were used as a large bore suction catheter and advanced to the affected sinus using a coaxial technique. Suction was performed using pump suction. At times, a stentriever was used as an anchor to facilitate advancing the suction catheter and to increase thrombectomy capabilities. RESULTS: Median decade of age was the 50s and nine patients were women. Fifty percent of the patients had multiple sinuses involved. All patients received systemic anticoagulation prior to endovascular aspiration thrombectomy. The most common reason to pursue endovascular aspiration thrombectomy in CVST patients was deterioration of initial clinical status (10/16). The mean time from admission to endovascular aspiration thrombectomy was 1.5 days (range 0-6 days). Good recanalization was obtained in all patients. There were no major peri-procedural complications. Most patients were discharged to either home or a rehabilitation facility. CONCLUSION: Endovascular aspiration treatment using large bore suction catheters for CVST is a safe and feasible approach for the treatment of anticoagulation refractory CVST. Heterogeneity of the clinical and radiological presentation requires further investigation to optimize patient selection before evaluating the efficacy of this technique in larger prospective studies.
BACKGROUND AND PURPOSE: Systemic anticoagulation is the standard treatment for cerebral venous sinus thrombosis (CVST). Several endovascular techniques have been described as salvage therapy for anticoagulation refractory CVST cases. We aim to evaluate the safety and feasibility of endovascular aspiration thrombectomy using the new generation, large bore suction catheters alone or in combination with stentriever devices for the treatment of CVST. METHODS: We collected data on 16 consecutive patients with CVST who received endovascular aspiration thrombectomy at three large academic centers. Second generation reperfusion catheters were used as a large bore suction catheter and advanced to the affected sinus using a coaxial technique. Suction was performed using pump suction. At times, a stentriever was used as an anchor to facilitate advancing the suction catheter and to increase thrombectomy capabilities. RESULTS: Median decade of age was the 50s and nine patients were women. Fifty percent of the patients had multiple sinuses involved. All patients received systemic anticoagulation prior to endovascular aspiration thrombectomy. The most common reason to pursue endovascular aspiration thrombectomy in CVST patients was deterioration of initial clinical status (10/16). The mean time from admission to endovascular aspiration thrombectomy was 1.5 days (range 0-6 days). Good recanalization was obtained in all patients. There were no major peri-procedural complications. Most patients were discharged to either home or a rehabilitation facility. CONCLUSION: Endovascular aspiration treatment using large bore suction catheters for CVST is a safe and feasible approach for the treatment of anticoagulation refractory CVST. Heterogeneity of the clinical and radiological presentation requires further investigation to optimize patient selection before evaluating the efficacy of this technique in larger prospective studies.
Authors: Fazeel M Siddiqui; Sudeepta Dandapat; Chirantan Banerjee; Susanna M Zuurbier; Mark Johnson; Jan Stam; Jonathan M Coutinho Journal: Stroke Date: 2015-04-21 Impact factor: 7.914
Authors: José M Ferro; Isabelle Crassard; Jonathan M Coutinho; Patrícia Canhão; Fernando Barinagarrementeria; Brett Cucchiara; Laurent Derex; Christoph Lichy; Jaime Masjuan; Ayrton Massaro; Gonzalo Matamala; Sven Poli; Mohammad Saadatnia; Erwin Stolz; Miguel Viana-Baptista; Jan Stam; Marie-Germaine Bousser Journal: Stroke Date: 2011-07-28 Impact factor: 7.914
Authors: K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek Journal: Lancet Date: 1991-09-07 Impact factor: 79.321
Authors: José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria Journal: Stroke Date: 2004-02-19 Impact factor: 7.914
Authors: Leonard Ll Yeo; Priscillia Ps Lye; Kong Wan Yee; Yang Cunli; Tu Tian Ming; Andrew Fw Ho; Vijay K Sharma; Bernard Pl Chan; Benjamin Yq Tan; Anil Gopinathan Journal: Clin Neuroradiol Date: 2020-06-11 Impact factor: 3.649
Authors: Philipp Bücke; Victoria Hellstern; Alexandru Cimpoca; José E Cohen; Thomas Horvath; Oliver Ganslandt; Hansjörg Bäzner; Hans Henkes Journal: J Clin Med Date: 2022-07-20 Impact factor: 4.964